You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Mallinckrodt
Boehringer Ingelheim
Baxter
Merck

Last Updated: August 6, 2020

DrugPatentWatch Database Preview

Silver sulfadiazine - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for silver sulfadiazine and what is the scope of patent protection?

Silver sulfadiazine is the generic ingredient in five branded drugs marketed by King Pharms Llc, Dr Reddys La, Thepharmanetwork Llc, and Franklin Pharms, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for silver sulfadiazine. Thirteen suppliers are listed for this compound.

Drug Prices for silver sulfadiazine

See drug prices for silver sulfadiazine

Drug Sales Revenue Trends for silver sulfadiazine

See drug sales revenues for silver sulfadiazine

Recent Clinical Trials for silver sulfadiazine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Yueyang Integrated Medicine HospitalPhase 2
SCARM Institute, Tabriz, IranPhase 2
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do CearaPhase 3

See all silver sulfadiazine clinical trials

Pharmacology for silver sulfadiazine
Medical Subject Heading (MeSH) Categories for silver sulfadiazine
Paragraph IV (Patent) Challenges for SILVER SULFADIAZINE
Tradename Dosage Ingredient NDA Submissiondate
SILVADENE CREAM;TOPICAL silver sulfadiazine 017381

US Patents and Regulatory Information for silver sulfadiazine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys La SSD silver sulfadiazine CREAM;TOPICAL 018578-001 Feb 25, 1982 AB RX No No   Start Trial   Start Trial   Start Trial
Dr Reddys La SSD AF silver sulfadiazine CREAM;TOPICAL 018578-003 Jul 11, 1990 DISCN No No   Start Trial   Start Trial   Start Trial
King Pharms Llc SILVADENE silver sulfadiazine CREAM;TOPICAL 017381-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Thepharmanetwork Llc THERMAZENE silver sulfadiazine CREAM;TOPICAL 018810-001 Dec 23, 1985 AB RX No No   Start Trial   Start Trial   Start Trial
Franklin Pharms SILDAFLO silver sulfadiazine DRESSING;TOPICAL 019608-001 Nov 30, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for silver sulfadiazine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms Llc SILVADENE silver sulfadiazine CREAM;TOPICAL 017381-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Franklin Pharms SILDAFLO silver sulfadiazine DRESSING;TOPICAL 019608-001 Nov 30, 1989   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Harvard Business School
Boehringer Ingelheim
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.